Gene Query: INIP

Dataset Description Geneva Score
Transcriptome analysis of U87 cells upon LINC00152 knockdown 75.19
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 17.81
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 17.81
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 15.4
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 14.95
Expression by CD133+ cells isolated from the adult human exocrine pancreas 14.29
RNAseq analysis of ESRP regulated splicing events in prostate cancer 14.13
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 13.76
MicroRNA-125a-5p overexpression in human macrophages 13.5
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 12.35
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 12.35
MYCL and EP400 are required for Max and MCPyV mediated gene activation 11.84
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 10.8
EP400 is required for Max and MCPyV mediated gene activation 10.69
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 10.43
Tracing Enhancer Networks using Epigenetic Traits (TENET) 9.72
Total RNA-seq in ALL-SIL upon JQ1 inhibition 9.69
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 9.45
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 8.72
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 8.44
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 8.26
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 8.26
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 8.21
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 8.21
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 7.86
3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations 7.84
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 7.71
Conservative alteration of chromosomal expression pattern across human solid tumor types 7.7
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 7.49
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 7.49
Widespread intronic polyadenylation diversifies immune cell transcriptomes 7.21
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 7.17
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 7.14
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 6.96
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 6.43
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 6.43
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 6.02
RNA-seq of YB5 cells treated with Proscillaridin A 6.02
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 6.01
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 6.01
Transcriptional profile in human S. haematobium infection 6.01
DART-seq: an antibody-free method for global m6A detection 6.01
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 5.99
SUV420H2 knockdown in PANC-1 5.87
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 5.84
Identification of global regulators of T-helper cell lineage specification 5.84
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 5.81
Comprehensive comparative analysis of 5’ end RNA sequencing methods 5.8
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 5.64
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 5.59
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 5.55
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 5.55
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 5.53
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 5.46
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 5.42
RNA-Seq profiling of days 0, 7 and 18 kidney organoids differentiated from three separate vials of starting material 5.42
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 5.41
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 5.39
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 5.38
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 5.22
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 5.22
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 5.19
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 5.17
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 5.16
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 [RNA-seq] 5.16
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 5.07
Effect of from Human Umbilical Vein Endothelial Cells 5.06
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_1A_PI3K_RNA-seq] 4.97
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 4.94
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 4.84
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 4.75
Generating Patterned Kidney Organoids for Studying Development and Diseases 4.68
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 4.66
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 4.66
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 4.62
MYC dependent mRNA translation shapes gene expression and cell biology 4.6
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 4.47
Identification of a LIF-responsive replication-competent human β cell 4.46
Regulation of protein translation during mitosis 4.43
HNF1A deficiency impairs β-cell fate, granule maturation and function 4.39
RNA-Sequencing of HepG2 cells treated with TGFBeta 4.37
A Unique Epigenomic Landscape Defines Human Erythropoiesis 4.36
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 4.36
RNAseq of T-ALL upon long non coding rna purturbation 4.31
CROP-Seq in Primary Human T Cells 4.3
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 4.28
Transcriptional profiles of normal human mature B cells 4.28
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 4.27
RIG-I and MDA5 fRIP during KSHV lytic reactivation 4.26
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 4.25
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 4.25
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 4.21
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 4.16
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 4.16
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 4.1
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 4.04
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 4.02
Integrating single-cell transcriptomic data across different conditions, technologies, and species 4.01
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 3.99
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 3.98
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 3.95
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 3.95
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 3.95
Altering cancer transcriptomes using epigenomic inhibitors 3.95
RNA seq comparison between scrambled and shGRP78 cells 3.94
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 3.89
LIN28A modulates splicing and gene expression programs in breast cancer cells 3.89
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 3.88
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 3.87
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 3.82
Identifying the molecular mode of action of itraconazole in colorectal cancer 3.8
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 3.76
scRNASeq analysis of cycling cardiomyocytes 3.76
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 3.75
Identification of renal resident macrophages across species 3.74
KSDM1b Role in Ewing Sarcoma 3.72
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 3.72
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 3.7
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 3.7
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 3.68
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 3.68
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 3.67
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 3.66
TGF-β regulation of miRNA expression in pancreatic cancer 3.66
Overexpression of NFIB and YBX1 in MCF-7 cells 3.65
Loss of CREBBP results in gene expression repression in lymphoma cells 3.59
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 3.59
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 3.56
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 3.55
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 3.54
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 3.54
Direct Isolation and Characterization of Human Nephron Progenitors. 3.53
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 3.51
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 3.49
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 3.49
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 3.49
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 3.46
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 3.45
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 3.43
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 3.41
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 3.41
RNASeq of mouse, human, and non-human primate primary dermal fibroblasts to poly(I:C) transfection 3.39
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 3.36
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 3.35
PRDM1 inhibits proliferation of human colon cancer organoids 3.35
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 3.35
The Genetic Landscape of Diamond-Blackfan Anemia 3.34
Targeting MTHFD2 in Acute Myeloid Leukemia 3.34
RNAseq Analysis in glioblastoma cells treated with Mepazine 3.34
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 3.33
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 3.32
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 3.32
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 3.31
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 3.31
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 3.3
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 3.28
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 3.28
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 3.28
Proteomics identifies a marker signature of MAPKi resistance in melanoma 3.26
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 3.24
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 3.24
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 3.24
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 3.23
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 3.23
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 3.23
Effect of PBK knockdown on C4-2 cell transcriptome 3.22
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 3.22
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 3.21
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 3.17
DAOY-Notch1/Notch2 knockout: transcriptome comparison 3.14
Trans-differentiation of human adult peripheral blood T cells into neurons 3.14
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma [longRNA] 3.13
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 3.11
Targeting EZH2 in MYCN-amplified Neuroblastoma 3.1
Targeting EZH2 in MYCN-amplified Neuroblastoma [RNA-seq] 3.1
Transcriptomic analysis of human tonsillar TFH subsets 3.09
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 3.08
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 3.08
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 3.08
4sU-seq of HFF exposed to salt and heat stress 3.07
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 3.06
The regulartory role of ZCCHC24 in splicing machinery 3.06
Differential expression of human parthenogenic stem cells, neural stem cells and DA progenitors. 3.06
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 3.04
A sister of NANOG regulates genes expressed in pre-implantation human development 3.02
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 3.01
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 3.01
Seletive inhibition of CDK9 in DLBCL cell lines 3.0
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 3.0
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 2.99
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 2.98
Single-cell transcriptomics of the human placenta: inferring the cell communication network of the maternal-fetal interface 2.98
Mitochondrial dsRNA triggers antiviral signalling in humans 2.98
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 2.97
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 2.97
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 2.96
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 2.94
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 2.94
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 2.94
Accurate annotation of human protein-coding small open reading frames 2.94
Silencing p300 in MCF7 cells to study expression and alternative splicing 2.93
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 2.9
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 2.9
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 2.88
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 2.87
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 2.84
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 2.84
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 2.8
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 2.8
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 2.79
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 2.79
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 2.78
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 2.76
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion 2.74
Identification of IL-27 as potent regulator of inflammatory osteolysis associated with vitamin E-blended ultra-high molecular weight polyethylene debris of orthopedic implants 2.71
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 2.71
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 2.7
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 2.69
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 2.68
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 2.68
Integrin signaling regulates YAP/TAZ to control skin homeostasis 2.68
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 2.66
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 2.66
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 2.64
Transcriptomes of oxLDL exposed trained monocytes 2.63
oxLDL exposed trained monocytes 2.63
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 2.63
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 2.6
SETDB1 compacts the inactive X chromosome in part through silencing an enhancer in the IL1RAPL1 gene 2.59
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 2.56
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 2.56
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 2.56
SLIGRL-induced gene expression changes in NHEK cells 2.54
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 2.54
Role for citron kinase in prostate cancer growth 2.53
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 2.52
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 2.52
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 2.52
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 2.52
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 2.51
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 2.5
Spliceosomal disruption of the non-canonical BAF complex in cancer 2.46
Global analysis of enhancer targets: Mosaic-seq 2.46
PTHrP overexpression in MCF7 cells 2.46
Novel Targeting of Transcription and Metabolism in Glioblastoma 2.41
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 2.39
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 2.38
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 2.38
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 2.37
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 2.35
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 2.34
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 2.34
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 2.32
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 2.32
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 2.32
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 2.32
Global epigenomic reconfiguration during mammalian brain development 2.31
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 2.28
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) 2.26
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 2.24
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 2.23
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 2.23
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 2.22
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 2.22
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 2.2
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 2.2
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 2.19
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 2.19
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 2.17
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 2.17
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 2.16
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 2.16
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 2.16
RNA-seq analysis of breast cancer 2.13
RNA-seq analysis and shRNA screen of breast cancer 2.13
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 2.13
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 2.12
RNA-Seq analysis RPE1 cells following exposure to Nutlin-3 to identify target genes of p53 [tpo12] 2.11
U2AF1 mutations alter splice site recognition in hematological malignancies 2.11
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 2.11
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 2.11
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 2.1
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 2.1
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 2.09
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 2.08
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 2.08
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 2.07
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 2.04
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 2.03
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 2.02
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 2.0
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 2.0
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 2.0
Effect of PRDM11 depletion in U2932 cells 1.97
Stem and effector CD8 T-cells from human cancers 1.97
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 1.96
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 1.96
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 1.95
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 1.93
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 1.9
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 1.9
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 1.9
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 1.9
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 1.9
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 1.83
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 1.81
Expression profiles of restoration of BAP1 in a BAP1 deficient cell line 1.8
Transcriptome analysis of BAP1 knockout and restoration 1.8
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 1.8
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 1.77
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 1.76
Epigenetic reprogramming of melanoma cells by vitamin C treatment 1.76
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 1.76
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 1.72
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 1.72
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 1.7
Electronic cigarettes 1.67
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 1.65
LIN28A Over-expression RNAseq 1.61
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 1.6
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 1.58
Effect of drugs on transcriptomic profiles 1.58
Gene expression profile of regenerated CD8αα T cells and CD8αβ T cells from LMP2 T-iPSCs 1.54
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 1.54
Identification of HOXB13 target genes responsive to BET inhibitors 1.52
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 1.49
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 1.49
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 1.49
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_human] 1.48
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 1.46
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 1.46
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 1.46
Gene expression signatures of innate lymphoid cells from human blood 1.45
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 1.45
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 1.44
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 1.43
single cell RNA-seq from GM12878 (ENCSR673UIY) 1.43
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 1.43
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 1.42
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 1.42
Active translatome profiling with RiboLace in MCF7 cells 1.41
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 1.4
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 1.4
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 1.38
Transcriptome of human ILC2s; primary vs IL-1b-primed 1.34
Mining the stiffness-sensitive transcriptome in human vascular smooth muscle cells identifies long non-coding RNA stiffness regulators 1.33
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 1.33
Total RNA-seq in ALL-SIL upon TLX1 knockdown 1.32
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 1.32
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 1.29
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 1.28
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 1.26
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 1.25
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 1.25
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 1.22
Differential expression analysis of RNA-seq data from melanocytes driven by tumor cell-derived exosomes 1.21
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 1.2
Transcriptional dependencies in diffuse intrinsic pontine glioma 1.19
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 1.18
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  1.17
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 1.17
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 1.16
Mutational landscape of splicing genes and functional consequences across 33 cancer types 1.16
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 1.14
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 1.14
RNA expression analysis upon JMJD1C depletion 1.13
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 1.13
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 1.13
Mapping interactions for the TNIP2 hub protein 1.13
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 1.12
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 1.12
Transcriptional changes in lymphoma cells induced by LSD1 depletion 1.09
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 1.09
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 1.09
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 1.09
RNA editing in nascent RNA affects pre-mRNA splicing 1.08
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 1.08
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 1.08
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 1.08
Small-molecule targeting of brachyury transcription factor addiction in chordoma 1.06
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 1.06
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 1.06
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 1.06
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 1.06
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 1.06
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 1.05
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 1.04
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 1.04
Functional significance of the HIV-1 Tat signature amino acid residues 1.03
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 1.03
Radiomic and gEnomic approaches for the enhanced DIagnosis of REnal Cancer (REDIRECt): A translational pilot study 1.01
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 0.99
K562 polyA RNA-Seq 0.98
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 0.96
TT-Seq captures the human transient transcriptome 0.96
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 0.95
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 0.95
Transcriptional profiling of LS1034 cells treated with tepoxalin 0.93
Effect of BMP inhibition or stimulation of primary human keratinocytes 0.93
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 0.93
Expression profiling of MCF-7 cells with treatment of TCDD 0.93
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 0.93
Gene expression profiling of human iPS cell-derived podocytes and sorted human adult podocytes 0.92
O-glcnAc reprograms cellular energetics 0.91
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 0.89
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 0.87
Metastasis in triple-negative breast cancer 0.87
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 0.87
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 0.87
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 0.87
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 0.84
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 0.81
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 0.81
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 0.81
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.8
CRIG identifies a novel population of highly phagocytic peritoneal macrophages associated with disease severity in patients with cirrhosis and ascites 0.79
BACH2 in human plasma cell fate decision 0.79
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 0.77
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 0.77
Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia 0.75
High-throughput RNAi cell viability screen to identify selective targets for EWS-FLI1 positive Ewing sarcoma 0.75
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 0.75
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 0.75
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 0.73
RNA-seq data 0.73
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 0.73
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 0.73
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 0.72
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 0.71
A20 regulates canonical wnt-signaling through an interaction with RIPK4 0.71
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 0.71
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 0.71
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 0.69
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.68
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 0.68
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 0.67
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 0.67
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 0.62
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 0.58
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 0.57
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma 0.57
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 0.57
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 0.55
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 0.52
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 0.52
The MEF2B Regulatory Network - RNA-seq data 0.52
The MEF2B Regulatory Network 0.52
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 0.5
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 0.5
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 0.5
Generation and persistence of human tissue-resident memory T cells in lung transplantation 0.5
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 0.47
Transcriptomes of human monocytes after ex vivo exposure to uric acid 0.47
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 0.44
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 0.44
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 0.44
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 0.43
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 0.43
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 0.42
Transcriptome analysis of peripheral blood monocytes 0.41
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 0.36
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 0.34
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.32
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma 0.32
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 0.31
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 0.26
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 0.23
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 0.22
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 0.22
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 0.22
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 0.21
Role of FGFR1 in neuronal devlopment 0.2
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 0.19
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 0.19
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 0.19
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 0.18
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 0.18
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model 0.17
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 0.16
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 0.13
Genome-wide analysis of the Integrator complex 0.12
Genome-wide analysis of the Integrator complex (HTS) 0.12
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 0.12
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 0.11
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 0.11
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 0.11
p53 activity results in DNA replication fork processivity 0.11
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 0.09
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 0.08
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 0.07
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 0.07
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 0.07
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 0.07
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.06
SOX11 knockdown in B-ALL cell lines 0.06
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 0.06
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.04
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.04
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 0.02
Novel Transcriptional Activity and Extensive Allelic Imbalance in the Human MHC Region 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation